Third-generation irreversible EGFR-TKI; Targeted for NSCLC with EGFR Ex19Del or EGFR L858R mutations; Active against CNS metastasis,
Sale!
Lucius
Replica Osimertinib EGFR-TKI Targeting EGFR Ex19Del and L858R Mutations
Original price was: $565.00.$406.00Current price is: $406.00.
Third-generation irreversible EGFR-TKI; Targeted for NSCLC with EGFR Ex19Del or EGFR L858R mutations; Active against CNS metastasis,
Reviews
There are no reviews yet.